• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性 COVID-19 感染期间衰老患者 T 细胞中 SARS-CoV-2 特异性 NLRP3 和 IL-1β 反应的差异。

Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection.

机构信息

Department of Biological Sciences, School of Dental Medicine, Case Western Reserve University, Cleveland, OH, United States.

Department of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, OH, United States.

出版信息

Front Immunol. 2023 Sep 18;14:1231087. doi: 10.3389/fimmu.2023.1231087. eCollection 2023.

DOI:10.3389/fimmu.2023.1231087
PMID:37799713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10548880/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes Coronavirus Disease 2019 (COVID-19) that presents with varied clinical manifestations ranging from asymptomatic or mild infections and pneumonia to severe cases associated with cytokine storm, acute respiratory distress syndrome (ARDS), and even death. The underlying mechanisms contributing to these differences are unclear, although exacerbated inflammatory sequelae resulting from infection have been implicated. While advanced aging is a known risk factor, the precise immune parameters that determine the outcome of SARS-CoV-2 infection in elderly individuals are not understood. Here, we found aging-associated (age ≥61) intrinsic changes in T cell responses when compared to those from individuals aged ≤ 60, even among COVID-positive patients with mild symptoms. Specifically, when stimulated with SARS-CoV-2 peptides , peripheral blood mononuclear cell (PBMC) CD4 and CD8 T cells from individuals aged ≥61 showed a diminished capacity to produce IFN-γ and IL-1β. Although they did not have severe disease, aged individuals also showed a higher frequency of PD-1 cells and significantly diminished IFN-γ/PD-1 ratios among T lymphocytes upon SARS-CoV-2 peptide stimulation. Impaired T cell IL-1β expression coincided with reduced NLRP3 levels in T lymphocytes. However, the expression of these molecules was not affected in the monocytes of individuals aged ≥61. Together, these data reveal SARS-CoV-2-specific CD4 and CD8 T-cell intrinsic cytokine alterations in the individuals older than 61 and may provide new insights into dysregulated COVID-directed immune responses in the elderly.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起 2019 年冠状病毒病(COVID-19),其临床表现从无症状或轻度感染和肺炎到与细胞因子风暴、急性呼吸窘迫综合征(ARDS)相关的严重病例,甚至死亡不等。导致这些差异的潜在机制尚不清楚,尽管已经暗示感染引起的炎症后遗症加剧与此有关。虽然高龄是已知的危险因素,但确定老年人感染 SARS-CoV-2 结局的确切免疫参数尚不清楚。在这里,我们发现与年龄≤60 岁的个体相比,年龄≥61 岁的个体的 T 细胞反应存在与衰老相关的内在变化,即使是 COVID-19 轻症患者也是如此。具体而言,用 SARS-CoV-2 肽刺激时,年龄≥61 岁的个体的外周血单核细胞(PBMC)CD4 和 CD8 T 细胞产生 IFN-γ和 IL-1β的能力减弱。尽管他们没有患重病,但老年个体在 SARS-CoV-2 肽刺激时,T 淋巴细胞中 PD-1 细胞的频率更高,IFN-γ/PD-1 比值明显降低。T 淋巴细胞中 IL-1β表达受损与 NLRP3 水平降低有关。然而,年龄≥61 岁个体的单核细胞中这些分子的表达不受影响。总之,这些数据揭示了年龄大于 61 岁的个体中 SARS-CoV-2 特异性 CD4 和 CD8 T 细胞内在细胞因子的改变,这可能为老年人 COVID 相关免疫反应失调提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/7322b631014b/fimmu-14-1231087-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/d6831aaa0785/fimmu-14-1231087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/7dd90a906191/fimmu-14-1231087-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/13ea876fb22f/fimmu-14-1231087-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/17270d37e1a0/fimmu-14-1231087-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/9f5b882cb054/fimmu-14-1231087-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/f15d7b5b3d1f/fimmu-14-1231087-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/7322b631014b/fimmu-14-1231087-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/d6831aaa0785/fimmu-14-1231087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/7dd90a906191/fimmu-14-1231087-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/13ea876fb22f/fimmu-14-1231087-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/17270d37e1a0/fimmu-14-1231087-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/9f5b882cb054/fimmu-14-1231087-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/f15d7b5b3d1f/fimmu-14-1231087-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6216/10548880/7322b631014b/fimmu-14-1231087-g007.jpg

相似文献

1
Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection.急性 COVID-19 感染期间衰老患者 T 细胞中 SARS-CoV-2 特异性 NLRP3 和 IL-1β 反应的差异。
Front Immunol. 2023 Sep 18;14:1231087. doi: 10.3389/fimmu.2023.1231087. eCollection 2023.
2
Detection of IFNγ-Secreting CD4 and CD8 Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2.检测外周血单个核细胞经活 SARS-CoV-2 刺激后 COVID-19 恢复期患者 IFNγ 分泌的 CD4 和 CD8 记忆 T 细胞。
Viruses. 2021 Jul 29;13(8):1490. doi: 10.3390/v13081490.
3
Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens.年龄相关的 SARS-CoV-2 刺突蛋白和核衣壳蛋白免疫反应差异。
In Vivo. 2023 Jan-Feb;37(1):70-78. doi: 10.21873/invivo.13055.
4
PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response.PD-1 阻断可逆转新冠后免疫异常,并刺激抗 SARS-CoV-2 免疫反应。
JCI Insight. 2021 Dec 22;6(24):e146701. doi: 10.1172/jci.insight.146701.
5
Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.危重新冠肺炎与独特的白细胞表型和转录组模式相关。
J Intern Med. 2021 Sep;290(3):677-692. doi: 10.1111/joim.13310. Epub 2021 Jun 3.
6
High Frequencies of Functional Virus-Specific CD4 T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders.嗅觉和味觉障碍的 SARS-CoV-2 患者中功能性病毒特异性 CD4 T 细胞的高频出现。
Front Immunol. 2021 Nov 10;12:748881. doi: 10.3389/fimmu.2021.748881. eCollection 2021.
7
Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.急危重症高血压患者的 SARS-CoV-2 特异性动态免疫。
Front Immunol. 2020 Dec 10;11:596684. doi: 10.3389/fimmu.2020.596684. eCollection 2020.
8
Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19.原发性人 T 细胞和单核细胞暴露于多克隆刺激物下会表现出基础易感性,导致细胞免疫应答受损,并发展为严重的 COVID-19。
Front Immunol. 2022 Jul 1;13:897995. doi: 10.3389/fimmu.2022.897995. eCollection 2022.
9
Impaired Cytotoxic CD8 T Cell Response in Elderly COVID-19 Patients.老年 COVID-19 患者细胞毒性 CD8 T 细胞应答受损。
mBio. 2020 Sep 18;11(5):e02243-20. doi: 10.1128/mBio.02243-20.
10
COVID-19 Impairs Immune Response to .COVID-19 损害了对... 的免疫反应。
Front Immunol. 2021 Feb 26;12:640644. doi: 10.3389/fimmu.2021.640644. eCollection 2021.

引用本文的文献

1
Bacterial infection in weaned piglets promotes diarrhea by inducing the NLRP3 inflammasome-pyroptosis pathway.断奶仔猪的细菌感染通过诱导NLRP3炎性小体-焦亡途径引发腹泻。
Sci China Life Sci. 2025 Jul 4. doi: 10.1007/s11427-024-2728-2.
2
Inhibition of RACK1-Mediated NLRP3 Oligomerization (Active Conformation) Ameliorates Acute Respiratory Distress Syndrome.抑制RACK1介导的NLRP3寡聚化(活性构象)可改善急性呼吸窘迫综合征。
Adv Sci (Weinh). 2025 Jul;12(27):e2411355. doi: 10.1002/advs.202411355. Epub 2025 May 11.
3
Immune Checkpoint Inhibitors in Geriatric Oncology.

本文引用的文献

1
SARS-COV-2 viroporins activate the NLRP3-inflammasome by the mitochondrial permeability transition pore.SARS-CoV-2 病毒穿孔蛋白通过线粒体通透性转换孔激活 NLRP3 炎症小体。
Front Immunol. 2023 Feb 20;14:1064293. doi: 10.3389/fimmu.2023.1064293. eCollection 2023.
2
Vaccines for the Prevention of Coronavirus Disease 2019 in Older Adults.用于预防老年人 2019 冠状病毒病的疫苗。
Infect Dis Clin North Am. 2023 Mar;37(1):27-45. doi: 10.1016/j.idc.2022.11.002. Epub 2022 Nov 4.
3
Interleukin-1β and Interleukin-10 Profiles and Ratio in Serum of COVID-19 Patients and Correlation with COVID-19 Severity: A Time Series Study.
老年肿瘤学中的免疫检查点抑制剂。
Curr Oncol Rep. 2024 May;26(5):562-572. doi: 10.1007/s11912-024-01528-3. Epub 2024 Apr 8.
新型冠状病毒肺炎患者血清中白细胞介素-1β和白细胞介素-10水平及比值与疾病严重程度的相关性:一项时间序列研究
Int J Gen Med. 2022 Nov 5;15:8043-8054. doi: 10.2147/IJGM.S381404. eCollection 2022.
4
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19.衰老、炎症衰老和免疫衰老作为重症 COVID-19 的风险因素。
Immun Ageing. 2022 Nov 11;19(1):53. doi: 10.1186/s12979-022-00309-5.
5
PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease.程序性死亡受体1/程序性死亡配体1阻断可消除重症β冠状病毒病中功能失调的天然-适应性免疫轴。
Sci Adv. 2022 Sep 23;8(38):eabn6545. doi: 10.1126/sciadv.abn6545. Epub 2022 Sep 21.
6
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic.COVID-19 大流行不断变化的格局中的 SARS-CoV-2 特异性 T 细胞。
Immunity. 2022 Oct 11;55(10):1764-1778. doi: 10.1016/j.immuni.2022.08.008. Epub 2022 Aug 18.
7
Inflammation, Immune Senescence, and Dysregulated Immune Regulation in the Elderly.老年人的炎症、免疫衰老及免疫调节失调
Front Aging. 2022 Apr 27;3:840827. doi: 10.3389/fragi.2022.840827. eCollection 2022.
8
Count on us: T cells in SARS-CoV-2 infection and vaccination.依靠我们:SARS-CoV-2感染和疫苗接种中的T细胞。
Cell Rep Med. 2022 Feb 25;3(3):100562. doi: 10.1016/j.xcrm.2022.100562. eCollection 2022 Mar 15.
9
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.COVID-19 康复者感染后 1 年的 SARS-CoV-2 特异性抗体和 T 细胞反应:一项纵向队列研究。
Lancet Microbe. 2022 May;3(5):e348-e356. doi: 10.1016/S2666-5247(22)00036-2. Epub 2022 Mar 23.
10
The T cell immune response against SARS-CoV-2.针对 SARS-CoV-2 的 T 细胞免疫应答。
Nat Immunol. 2022 Feb;23(2):186-193. doi: 10.1038/s41590-021-01122-w. Epub 2022 Feb 1.